Hyderabad, India—September 26, 2024 Bioserve Biotechnologies (India) Pvt. Ltd., a REPROCELL company, is thrilled to announce the launch of PreciOnc, a groundbreaking service that brings at-home genetic testing for hereditary cancer risk, including breast cancer, directly to consumers. With PreciOnc, individuals can assess their genetic risk from the comfort of their own home, with no need for a doctor’s referals or invasive blood draws. The service will be available through www.precionc.com 

The launch event will be held on September 26, 2024, at Pinnacle Towers, Hyderabad, with Dr. Mounika Boppana as the chief guest.

PreciOnc offers two key services:

• PreciOnc-Presight focuses on assessing genetic risk for hereditary cancers like breast cancer by analyzing genes such as BRCA 1 & 2.
• PreciOnc-Inheritica provides a comprehensive look at inherited cancer risks, covering a broader spectrum of genetic markers linked to other cancers, including ovarian and colorectal cancer.

With the introduction of PreciOnc, we’re putting the power of personalized cancer risk assessment directly into the hands of individuals. No longer do patients need to visit a clinic or rely on a doctor’s referral. They can now conveniently collect their saliva sample at home and receive a detailed report outlining their genetic risk.

How PreciOnc Works:

1. Order Your Kit: Customers can order their PreciOnc genetic testing kit online without the need for a prescription.
2. Collect Your Sample: Using the saliva collection kit, individuals can provide their sample easily at home by following simple instructions.
3. Send It Back: Return the sample using the prepaid shipping label. Bioserve’s advanced laboratories will handle the genetic analysis.
4. Get Your Results: Customers receive a comprehensive genetic report, giving them valuable insights into their risk for hereditary cancers.

Empowering Personalized Cancer Care
PreciOnc services are part of Bioserve’s commitment to advancing personalized medicine by making genetic testing more accessible. Whether you have a family history of cancer or are simply proactive about your health, PreciOnc provides actionable insights to help manage your risk.

About Bioserve Biotechnologies:

Bioserve Biotechnologies (India) Pvt. Ltd., a REPROCELL company, is a pioneer in providing cutting-edge biotechnological solutions. With over 20 years of expertise, we deliver high-quality services across the nation. Our core competencies extend to oligosynthesis and molecular services, establishing us as a trusted name in the industry.

Part of the global Reprocell Group, a Tokyo Stock Exchange-listed company headquartered in Yokohama Japan, our capabilities have grown significantly. We offer a diverse range of services, including nucleic acid processing, sequencing, gene expression analysis, and genotyping, enabling us to better serve our clients both in India and around the world.

For more information, please visit: Bioserve.in and PreciOnc.com